People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Biotechnology, Hospitals and Physicians
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Novalent Biotech, Inc. | — | Biotechnology | Series A | $11.0M | $211.9M | 2021 |
| Progressive Acute Care, LLC | — | Hospitals and Physicians | Series A | $7.8M | $56.3M | 2009 |
Wayne Thompson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wayne Thompson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dan Newell | 1 | 3 |
| Kevin Parrish | 1 | 1 |
| Alex Ovchar | 1 | 1 |
| Dan Rissing | 1 | 1 |
| Joel Longtin | 1 | 1 |
| Michael Genoff | 1 | 1 |
| Mike Hulburt | 1 | 1 |
| Bill Massa | 1 | 1 |
| Mike Hurlburt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.